Poseida Therapeutics
PSTX
#6104
Rank
โ‚ฌ0.78 B
Marketcap
8,09ย โ‚ฌ
Share price
0.00%
Change (1 day)
182.59%
Change (1 year)

EPS for Poseida Therapeutics (PSTX)

EPS in 2024 (TTM): -0,67ย โ‚ฌ

According to Poseida Therapeutics's latest financial reports the company's current EPS (TTM) is -0,60ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,93ย โ‚ฌ an increase over its 2021 EPS that were of -1,72ย โ‚ฌ.

EPS history for Poseida Therapeutics from 2020 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-0,67ย โ‚ฌ
2022-0,93ย โ‚ฌ-46.04%
2021-1,72ย โ‚ฌ-9.59%
2020-1,90ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,47ย โ‚ฌ 143.66%๐Ÿ‡บ๐Ÿ‡ธ USA